This company owns 22 trademarked medicine brand names that are used in treating several diabetic, cardiac (including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), hypertension, narcolepsy, Parkinson’s, dyslipidemia, schizophrenia, depression, mania, all neuropathy and neuro-related disorders.
Value Drivers
Reason for Sale
The primary owner wishes to retire early and invest the sales proceeds for passive income mainly due to their health condition that needs more relaxation.
Team
The team consists of the owner as the CEO.
Business Model
The company is modestly priced in comparison to the generic pharma trading multiples in India.